Categories: Defined Benefit

August 15, 2023
Our analysis of private credit activity in 2Q23.
August 14, 2023
Joe McGuane analyzes hedge fund performance in 2Q23.
August 14, 2023
Callan Public DB Plan Focus Group provides an update on plan returns and analysis of how they compare over time.
August 14, 2023
This blog post is one in a series of monthly updates about the impact of interest rates on corporate defined benefit (DB) plans.
August 12, 2023
Gary Robertson provides an update on private equity activity in 2Q23, from fundraising to exits.
August 11, 2023
Kristin Bradbury, Munir Iman, and Aaron Quach analyze real estate and other real assets' performance in 2Q23.
August 3, 2023
Mark Wood analyzes the special rebalance implemented by the Nasdaq-100.
July 18, 2023
Kristin Bradbury assesses the global stock and bond markets in 2Q23.
July 7, 2023
Kristin Bradbury assesses the global economy in 2Q23 and what it might hold for the rest of the year.
July 6, 2023
We provide a summary of our Callan 2023 Private Credit Fees and Terms Study
7 8 9

Callan Family Office

You are now leaving Callan LLC’s website and going to Callan Family Office’s website. Callan Family Office is not affiliated with Callan LLC.  Callan LLC has licensed the Callan® trademark to Callan Family Office for use in providing investment advisory services to ultra-high net worth clients, family foundations, and endowments. Callan Family Office and Callan LLC are independent, unaffiliated investment advisory firms separately registered with the Securities and Exchange Commission under the Investment Advisers Act of 1940.

Callan LLC is not responsible for the services and content on Callan Family Office’s website. Inclusion of this link does not constitute or imply an endorsement, sponsorship, or recommendation by Callan LLC of their website, or its contents, and Callan LLC is not responsible or liable for your use of it. When visiting their website, you are subject to Callan Family Office’s terms of use and privacy policies.